The Cancer Alliance Regional Genomic Service is dedicated to educating healthcare professionals across the East of England. We are unable to take direct clinical referrals or receive patient identifiable information. We are also unable to provide direct medical advice or engage with patients regarding their personal care. If you have questions about your treatment, we encourage you to speak with your healthcare team, who are best placed to guide and support you.
The Regional Genomic Practitioner Service
Comprehensive genomic sequencing offers patients with cancer the possibility of receiving a more precise diagnosis at the start of their treatment pathway. This can provide prognostic information and guide faster access to precision treatments or surgical intervention. Knowledge of a patients complete genomic profile helps to avoid drug toxicities and enables access to molecularly stratified clinical trials. Equally important, it may also identify at risk family members who may be eligible for risk stratification and cancer prevention strategies.
Adoption of genomics into cancer care needs a clinical workforce with understanding of how and where genomic testing fits into current clinical pathways and how to use it.
The Genomic Clinical Practitioners are working across the East of England Cancer Alliances geography to deliver the genomics agenda. The Genomic Clinical Practitioners will work with the three Genomic Medical Service Alliances and their associated Genomic Laboratory Hubs that map into the East of England Cancer Alliance Geography, ensuring that relationships are built with the Medical Genetics Services that align to all localities. The service will facilitate, support and engage with primary and secondary care colleagues to develop pathways and embed genomic testing and/or advice for all service users in cancer care.
Contact the Regional Genomic Clinical Practitioner Service on:
cpicb.eoegenomicsteam@nhs.net
All emails will be directed to the correct practitioner for your area.

Metastatic malignant disease of unknown primary origin in adults: diagnosis and management
ctDNA testing for CUP patients
From 15th July 2026, patients with CUP can be referred for circulating tumour DNA (ctDNA) testing via the NHS Genomic Test Directory.
Already used in non-small cell lung cancer (NSCLC), ctDNA testing uses a simple blood test to detect tumour DNA circulating in the bloodstream.
For patients with CUP, this can help:
- Identify the likely tissue of origin
- Detect clinically actionable genomic alterations
- Support diagnosis, treatment decisions and access to clinical trials
To support this rollout, the national genomics unit have produced educational webinars to walk through referral pathways and what this means in practice. The relevant webinar for our region took place on the 7th July, see recording and slides here:
If you require any further information on how to action testing for your patients, please do get in touch.
Whole Genome Sequencing for suspected cancer - Information for patients and family members
North Thames Genomics - ctDNA project explained
North Thames Genomics - circulating tumour DNA
East Genomics - Circulating Tumour DNA
East Genomics - Phase III ctDNA Lung Cancer Program
ctDNA Guidance for Clinicians for Patients with Advanced Lung Cancer
Genomics: Lung cancer and somatic variants | Macmillan Cancer Support
Results from the Cancer Prevention Project 3 trial | Bowel Cancer UK
RM Partners - Lynch Syndrome Quick Guide for Primary Care Clinicians - Please refer to the new UKCCG Guidelines below for aspirin dosage
FAQ for management Guidelines for MLH1, MSH2, MSH6 and PMS2 Germline - UKCCG Guidelines 2025
Lynch Syndrome e-learning for Primary Care Practitoners
New app launched to support estimated 175,000 people in the UK with Lynch Syndrome | East Genomics
The Role of Genomics in Primary Care - Gateway C (free course)
Join the thousands of healthcare staff using the QGenome app
Clinicians across the East Midlands and East of England can now have genomic referral, risk assessment and testing guidance in the palm of their hand, thanks to an NHSE-funded app called QGenome. The app, which can be downloaded for iOS and Android devices (with a web-based version also available) is based on national guidelines including NHS England’s National Genomic Test Directory. The app currently supports clinicians in the areas of cancer, cardiology, renal, prenatal and primary care. Some feedback from clinicians currently using the app includes:
- “Incredibly useful. Feels like I have a Genetic Counsellor on my shoulder.”
- “For someone new to genomics it has been invaluable in understanding eligibility pathways and has improved my knowledge and ability to speak to patients about their concerns.”
- “User friendly. Great educational and clinical decision support tool.”
You can find out more, including how to download the app on the QGenome website.
To watch a demo of the app by Dr Anju Kulkarni (one of the creators), please click here.
Important concepts in cancer cell biology and genetics - Training Science Communicated Ltd
Session 1 - Cancer cell biology
Session 2 - Targeted therapies
Session 3 - Immunotherapy
Session 4 - Precision cancer medicine
P1 (Includes session 1 & 2) - Click here to watch
P2 (Includes session 3 & 4) - Click here to watch
- Introduction to cancer treatments
- Using small molecules as cancer treatments
- Using antibodies as cancer treatments
- How does chemotherapy work?
- Hormone therapy for cancer
- Targeted cancer treatments
- Kinase inhibitor cancer treatments
- Immunotherapy
- Immune checkpoint inhibitors
- Living cells as cancer treatments
Communities of Practice
East Genomics are supporting 16 Genomics Communities of Practice to support healthcare staff across specialities and job roles to share best practice, upskill and better integrate genomic medicine into their clinical practice.
For cancer these include:
Urology / Lung / CUP / Paediatric, teenage & young adult haemato-oncology / Pancreatic / Haemato-oncology / Gynaecological Oncology.
This link will take you to view each of the Communities of Practice including who is leading it, a schedule of upcoming meetings, how to join, and where to access slides and recordings from previous meetings
https://www.eastgenomics.nhs.uk/for-healthcare-professionals/east-genomics-communities-of-practice/
Regional Genomic Practitioner Service Webinar - October 2024, can be viewed here.
Genomics in Primary Care Webinar - May 2025, can be viewed here.
ICS Cancer Educational Webinar - Genomics - July 2025, can be viewed here.
Our Voices, Our Stories: Lived Experiences of Genomic Testing Webinar - August 2025, can be viewed here.
CanRisk for Breast Cancer Training Session - NHS East Genomics August 2025, can be viewed here.
Genomics Webinar, Primary Care - December 2025, can be viewed here.
Genomic Testing in Pancreatic Cancer webinar - 14th January 2026, can be viewed here.
Pancreatic Cancer & Genomics - Implementation of mainstream testing - March 2026, can be viewed here.
TNBC: Genomics and Pathology - April 2026, can be viewed here.
Digitising the Genomic Test Directory - April 2026, can be viewed here.
Let's Talk About Cancer - Genomics, how we use DNA to inform cancer diagnosis and treatment options - July 2026, can be viewed here.
If you are a healthcare professional and would like to sign up to our newsletter, please email: cpicb.eoegenomicsteam@nhs.net
June
Important change to requesting diagnostic cancer genetic testing (inherited cancers)
July
UK Government announce new 10 Year Plan for the NHS
August
Nurses to lead new genomic services, Westminister Government announces
October
Solid cancer service updates - Cambridge Lab
New ordering and reporting details for cancer testing at East Genomics, Cambridge
RNAlater can be used to collect WGS samples without the need for freezing
VR Module: Lynch Syndrome - click here to view.
Quick fact guide
Flow Chart
Standard Operating Procedure (SOP)
NHS East Genomics Lynch Syndrome app
UKCCG guidelines 2025 FAQ for Management Guidelines for MLH1, MSH2, MSH6, and PMS2 Germline
Aspirin and Lynch Syndrome – Frequently Asked Questions (FAQ) for People with Lynch Syndrome
Results from the Cancer Prevention Project 3 trial | Bowel Cancer UK
The NHS Jewish BRCA Testing Programme closed on 31st October 2025. Updates will follow accordingly.